KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Depreciation & Amortization (CF) (2016 - 2026)

Medtronic (MDT) has disclosed Depreciation & Amortization (CF) for 13 consecutive years, with $749.0 million as the latest value for Q1 2026.

  • Quarterly Depreciation & Amortization (CF) rose 9.5% to $749.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.1 billion through Jan 2026, up 15.21% year-over-year, with the annual reading at $2.9 billion for FY2025, 8.08% up from the prior year.
  • Depreciation & Amortization (CF) hit $749.0 million in Q1 2026 for Medtronic, up from $745.0 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $840.0 million in Q2 2025 to a low of $649.0 million in Q1 2024.
  • Historically, Depreciation & Amortization (CF) has averaged $694.5 million across 5 years, with a median of $675.0 million in 2024.
  • Biggest five-year swings in Depreciation & Amortization (CF): dropped 4.42% in 2024 and later rose 28.44% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $671.0 million in 2022, then grew by 0.15% to $672.0 million in 2023, then grew by 0.45% to $675.0 million in 2024, then grew by 10.37% to $745.0 million in 2025, then grew by 0.54% to $749.0 million in 2026.
  • Business Quant data shows Depreciation & Amortization (CF) for MDT at $749.0 million in Q1 2026, $745.0 million in Q4 2025, and $748.0 million in Q3 2025.